Cargando…

Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes

BACKGROUND: Because of the increased risk for severe coronavirus disease 2019 (COVID-19), the Advisory Committee on Immunization Practices (ACIP) initially prioritized COVID-19 vaccination for persons in long-term care facilities (LTCF), persons aged ≥65 years, and persons aged 16–64 years with high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sami, Samira, Tenforde, Mark W, Talbot, H Keipp, Lindsell, Christopher J, Steingrub, Jay S, Shapiro, Nathan I, Ginde, Adit A, Douin, David J, Prekker, Matthew E, Erickson, Heidi L, Brown, Samuel M, Peltan, Ithan D, Gong, Michelle N, Khan, Akram, Exline, Matthew C, Files, D Clark, Gibbs, Kevin W, Rice, Todd W, Casey, Jonathan D, Grijalva, Carlos G, Stubblefield, William B, Womack, Kelsey N, Hager, David N, Qadir, Nida, Chang, Steven Y, Henning, Daniel J, Wilson, Jennifer G, Self, Wesley H, Patel, Manish M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136001/ https://www.ncbi.nlm.nih.gov/pubmed/33977301 http://dx.doi.org/10.1093/cid/ciab319

Ejemplares similares

Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes
por: Ward, Michael J., et al.
Publicado: (2022)

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
por: Tenforde, Mark W., et al.
Publicado: (2021)

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
por: Turbyfill, Caitlin, et al.
Publicado: (2022)

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
por: Stephenson, Meagan, et al.
Publicado: (2022)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
por: Tenforde, Mark W., et al.
Publicado: (2022)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)

2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
por: DeCuir, Jennifer, et al.
Publicado: (2023)

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
por: Surie, Diya, et al.
Publicado: (2023)

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
por: Lauring, Adam S, et al.
Publicado: (2022)

Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress
por: Han, Jin H., et al.
Publicado: (2022)

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
por: Tenforde, Mark W., et al.
Publicado: (2020)

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023
por: Surie, Diya, et al.
Publicado: (2023)

Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities — United States, July 2020
por: Fisher, Kiva A., et al.
Publicado: (2020)

Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020
por: Fisher, Kiva A., et al.
Publicado: (2020)

Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States
por: Fisher, Kiva A., et al.
Publicado: (2021)

Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020
por: Tenforde, Mark W., et al.
Publicado: (2020)

What’s Taking So Long? Known Unknowns, Capacity Strain, and Hospital-acquired Sepsis
por: Bowman, Amelia, et al.
Publicado: (2022)

1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023
por: Yuengling, Katharine, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
por: Stubblefield, William B, et al.
Publicado: (2020)

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
por: Linderman, Susanne L., et al.
Publicado: (2022)

Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia
por: Moskowitz, Ari, et al.
Publicado: (2022)

Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial
por: Kaizer, Alexander M., et al.
Publicado: (2022)

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
por: Tenforde, Mark W., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
por: Self, Wesley H., et al.
Publicado: (2020)

A multicenter cluster randomized, stepped wedge implementation trial for targeted normoxia in critically ill trauma patients: study protocol and statistical analysis plan for the Strategy to Avoid Excessive Oxygen (SAVE-O2) trial
por: Dylla, Layne, et al.
Publicado: (2021)

Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020
por: Self, Wesley H., et al.
Publicado: (2020)

The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
por: Hendrickson, Kathryn W., et al.
Publicado: (2021)

Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019
por: Marvi, Tanya K., et al.
Publicado: (2021)

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
por: Kaizer, Alexander M., et al.
Publicado: (2023)

Modifiable in‐hospital factors for 12‐month global cognition, post‐traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID‐19
por: Han, Jin H., et al.
Publicado: (2023)

Do the Right Thing
por: Lanspa, Michael J., et al.
Publicado: (2020)

Exposures in adult outpatients with COVID‐19 infection during early community transmission, Tennessee
por: Tenforde, Mark W., et al.
Publicado: (2020)

Time-of-day dependent effects of midazolam administration on myocardial injury in non-cardiac surgery
por: Prin, Meghan, et al.
Publicado: (2022)

Organization of Outpatient Care After COVID-19 Hospitalization
por: Valley, Thomas S., et al.
Publicado: (2022)

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
por: Douin, David J., et al.
Publicado: (2022)

Role of Tier-0, Tier-1 and Tier-2 Regional Centers in CMS DC04
por: Barrass, T, et al.
Publicado: (2004)

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
por: Tenforde, Mark W., et al.
Publicado: (2021)

Early Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19
por: Lanspa, Michael J., et al.
Publicado: (2023)

Reply: From the “Door-to-Antibiotic” to the “Antibiotic-at-Door” Concept?
por: Peltan, Ithan D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7uqc4lnc28i5j0atrofl5utcc7